ursodeoxycholic acid has been researched along with Metabolic Syndrome in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 10 (83.33) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, JH; Heo, NY; Hwang, JS; Jeong, SJ; Kim, E; Kim, TO; Lee, J; Oh, EH; Park, J; Park, SH; Park, YE | 1 |
| Bae, JS; Cha, JY; Hahm, KB; Han, YM; Ko, KH; Lee, HJ; Oh, BC; Park, JM | 1 |
| Dehghanian, A; Dorvash, MR; Firouzabadi, N; Khoshnood, MJ; Mosaddeghi, P; Saber, H | 1 |
| Ivashkin, KV; Ivashkin, VT; Leshchenko, VI; Liusina, EO; Lunkov, VD; Maevskaya, MV; Zozula, VN | 1 |
| Henry, L; Mehta, R; Mishra, A; Reyes, MJ; Younossi, ZM | 1 |
| Baldo, V; Canesso, F; Cazzagon, N; Floreani, A; Franceschet, I; Salmaso, L | 1 |
| Avalueva, EB; Ivanov, SV; Lapinskiĭ, IV; Orishak, EA; Skazyvaeva, EV; Tkachenko, EI | 1 |
| Elshazly, SM; Mahmoud, AA | 1 |
| Gavrilova, NP; Radchenko, VG; Seliverstov, PV; Tatarova, NA | 1 |
| Akhmedov, VA; Gaus, OV | 1 |
| Alawad, AS; Levy, C | 1 |
| Abel, T; Fehér, J | 1 |
5 review(s) available for ursodeoxycholic acid and Metabolic Syndrome
| Article | Year |
|---|---|
Emerging Targets to Relieve Fat Stress-Induced Liver Diseases: UDCA, Tocotrienol, ω-3 PUFAs, and IgY Targeted NPC1L1 Cholesterol Transporter.
Topics: Animals; Carcinoma, Hepatocellular; Drug Design; Fatty Acids, Omega-3; Humans; Immunoglobulins; Liver Cirrhosis; Liver Neoplasms; Membrane Proteins; Membrane Transport Proteins; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease; Obesity; Tocotrienols; Ursodeoxycholic Acid | 2017 |
Non-alcoholic fatty liver disease as a cause and consequence of cardio-metabolic complications. Role of the ursodeoxicholic acid in the pharmacotherapy.
Topics: Cholagogues and Choleretics; Humans; Hypertension; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease; Risk Factors; Ursodeoxycholic Acid | 2019 |
Systematic review with meta-analysis: non-alcoholic steatohepatitis - a case for personalised treatment based on pathogenic targets.
Topics: Bariatric Surgery; Fatty Liver; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lactones; Metabolic Syndrome; Metformin; Non-alcoholic Fatty Liver Disease; Orlistat; Precision Medicine; Thiazolidinediones; Ursodeoxycholic Acid; Vitamin E; Weight Loss | 2014 |
FXR Agonists: From Bench to Bedside, a Guide for Clinicians.
Topics: Animals; Azepines; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholestasis; Drug Evaluation, Preclinical; Gastrointestinal Agents; Hepatitis, Autoimmune; Humans; Hypertension, Portal; Indoles; Isoxazoles; Liver Cirrhosis, Alcoholic; Liver Cirrhosis, Biliary; Liver Diseases; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease; Receptors, Cytoplasmic and Nuclear; Ursodeoxycholic Acid | 2016 |
[Non-alcoholic fatty liver disease and cardiovascular risk].
Topics: Antioxidants; Atherosclerosis; Carcinoma, Hepatocellular; Cardiovascular Diseases; Cytokines; Exercise; Fatty Acids, Nonesterified; Fatty Liver; Feeding Behavior; Humans; Insulin Resistance; Life Style; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Metabolic Syndrome; Obesity; Triglycerides; Ursodeoxycholic Acid | 2008 |
2 trial(s) available for ursodeoxycholic acid and Metabolic Syndrome
| Article | Year |
|---|---|
Efficacy and Safety of Biphenyl Dimethyl Dicarboxylate and Ursodeoxycholic Acid Combination in Chronic Hepatitis Related to Metabolic Syndrome Components.
Topics: Alanine Transaminase; Biphenyl Compounds; Hepatitis, Chronic; Humans; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease; Ursodeoxycholic Acid | 2021 |
[Approaches to the treatment of patients with climacteric disorders complicated with menopausal metabolic syndrome with cholestasis].
Topics: Body Mass Index; Cholagogues and Choleretics; Cholestasis; Drug Therapy, Combination; Estrogen Replacement Therapy; Female; Humans; Menopause; Metabolic Syndrome; Middle Aged; Treatment Outcome; Ultrasonography; Ursodeoxycholic Acid | 2014 |
5 other study(ies) available for ursodeoxycholic acid and Metabolic Syndrome
| Article | Year |
|---|---|
Metformin treatment prevents gallstone formation but mimics porcelain gallbladder in C57Bl/6 mice.
Topics: Animals; Calcinosis; Cholagogues and Choleretics; Cholesterol; Diabetes Mellitus, Type 2; Diet, High-Fat; Disease Models, Animal; Gallbladder; Gallbladder Diseases; Gallstones; Humans; Hypoglycemic Agents; Male; Metabolic Syndrome; Metformin; Mice; Mice, Inbred C57BL; Ursodeoxycholic Acid | 2018 |
Metabolic syndrome associated with primary biliary cirrhosis.
Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Angina, Stable; Cholagogues and Choleretics; Female; Humans; Ischemic Attack, Transient; Kaplan-Meier Estimate; Liver Cirrhosis, Biliary; Male; Metabolic Syndrome; Middle Aged; Myocardial Infarction; Survival Rate; Ursodeoxycholic Acid | 2015 |
[Efficiency of ursodeoxycholic acid therapy in non-alcoholic fatty liver disease associated with metabolic syndrome].
Topics: Adult; Cholagogues and Choleretics; Fatty Liver; Female; Humans; Intestinal Mucosa; Intestines; Male; Metabolic Syndrome; Middle Aged; Non-alcoholic Fatty Liver Disease; Russia; Time Factors; Ursodeoxycholic Acid | 2013 |
Ursodeoxycholic acid ameliorates fructose-induced metabolic syndrome in rats.
Topics: Animals; Blood Glucose; Blood Pressure; Body Weight; Cholesterol; Fenofibrate; Fructose; Glutathione; Glycation End Products, Advanced; Insulin; Insulin Resistance; Male; Malondialdehyde; Metabolic Syndrome; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidative Stress; Rats; Rats, Wistar; Triglycerides; Uric Acid; Ursodeoxycholic Acid | 2014 |
[DYNAMIC OF CLINICAL, LABORATORY AND SONOGRAPHIC PARAMETERS AFTER SUCCESSFUL LITHOLITIC THERAPY AT PATIENTS WITH GALLSTONE DISEASE IN ASSOCIATION WITH METABOLIC SYNDROME].
Topics: Adult; Aged; Female; Gallstones; gamma-Glutamyltransferase; Humans; Male; Matrix Metalloproteinase 9; Metabolic Syndrome; Middle Aged; Tissue Inhibitor of Metalloproteinase-1; Ultrasonography; Ursodeoxycholic Acid | 2015 |